Get the Stockscreener App
2.1451
18.28%
-0.4799
Niki BioSolutions, Inc. Common Stock Stock (NIKI) Forecast
The Niki BioSolutions, Inc. Common Stock (NIKI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.4721, representing a +61.86% increase from the current price of $2.1451. The highest analyst price target is $4.7736, and the lowest is $2.1707.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NIKI Price Target
Average 6.8812
(+220.79% Upside)
Is Niki BioSolutions, Inc. Common Stock (NIKI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 19.00 | Buy |
| STOCH(9,6) | 6.2256 | Buy |
| STOCHRSI(14) | 27.83 | Neutral |
| MACD(12,26) | -0.8912 | Sell |
| ADX(14) | 20.45 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | -230.94 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.9858
Sell
|
3.6687
Sell
|
| MA20 |
4.4189
Sell
|
4.3723
Sell
|
| MA50 |
6.25
Sell
|
6.142
Sell
|
| MA100 |
4.2224
Sell
|
0.00
Buy
|
| MA200 |
2.1112
Buy
|
0.00
Buy
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, NIKI could be considered a Strong Sell, with 17 technical analysis indicators signaling 6 Buy signals, 9 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on NIKI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 19 indicates that NIKI is oversold. This indicates that NIKI price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 6.2256 indicates that NIKI is oversold. This indicates that NIKI price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 27.83 indicates that NIKI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.45 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -230.94 indicates that NIKI is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term NIKI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Niki BioSolutions, Inc. Common Stock financial reports and earnings history, Niki BioSolutions, Inc. Common Stock (NIKI) stock could reach $54.09 by 2030, $280.80 by 2040 and $499.02 by 2050. See the projected annual prices until 2050 of the Niki BioSolutions, Inc. Common Stock stock below:
- Niki BioSolutions, Inc. Common Stock (NIKI) is expected to reach an average price of $68.59 in 2035, with a high prediction of $102.56 and a low estimate of $68.64. This indicates an $3,098% rise from the last recorded price of $2.1451.
- Niki BioSolutions, Inc. Common Stock (NIKI) stock is projected to chart a bullish course in 2040, with an average price target of $240.62, representing an $11,117% surge from its current level. The forecast ranges from a conservative $85.50 to a sky-high $280.80.
- Our analysts predict Niki BioSolutions, Inc. Common Stock (NIKI) to jump 9,978% by 2045, soaring from $216.25 to an average price of $216.18, potentially reaching $291.46. While $216.25 is the low estimate, the potential upside is significant.
- Niki BioSolutions, Inc. Common Stock (NIKI) stock is expected to climb by 2050, reaching an average of $502.88, a $23,343% jump from its current level. However, a wide range of estimates exists, with high and low targets of $499.02 and $152.18, respectively, highlighting the market's uncertainty.
Niki BioSolutions, Inc. Common Stock Stock (NIKI) Year by Year Forecast
Niki BioSolutions, Inc. Common Stock Stock (NIKI) Price Forecast for 2026
The predicted value for Niki BioSolutions, Inc. Common Stock (NIKI) in 2026 is set at an average of $6.5076. Estimates vary from a peak of $12.24 to a trough of $0.7751, indicating an +203.37% surge from the present price of $2.1451.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $2.4807 | $2.1707 | $4.7736 | +15.64% |
| December, 2026 | $1.6177 | $1.1965 | $5.6099 | -24.59% |
Niki BioSolutions, Inc. Common Stock Stock (NIKI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Niki BioSolutions, Inc. Common Stock (NIKI) is $9.844, with a high forecast of $19.45 and a low forecast of $0.2398. This indicates an +358.91% increase from the last price of $2.1451.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.2398 | $0.2398 | $2.7455 | -88.82% |
| February, 2027 | $1.8042 | $2.4442 | $1.6713 | -15.89% |
| March, 2027 | $1.8116 | $1.8416 | $1.6087 | -15.55% |
| April, 2027 | $0.4476 | $0.5026 | $1.1446 | -79.14% |
| May, 2027 | $7.8591 | $0.429 | $7.5969 | +266.38% |
| June, 2027 | $6.278 | $6.588 | $6.3214 | +192.67% |
| July, 2027 | $4.6669 | $4.9069 | $4.7825 | +117.56% |
| August, 2027 | $16.56 | $2.6436 | $12.70 | +671.97% |
| September, 2027 | $11.41 | $12.41 | $13.52 | +431.98% |
| October, 2027 | $9.3333 | $9.3633 | $10.37 | +335.10% |
| November, 2027 | $4.8581 | $4.8581 | $7.9162 | +126.47% |
| December, 2027 | $19.09 | $5.4759 | $19.45 | +790.02% |
Niki BioSolutions, Inc. Common Stock Stock (NIKI) Price Forecast for 2028
In 2028, Niki BioSolutions, Inc. Common Stock (NIKI) is projected to reach an average price of $22.36, with a high projection of $37.64 and a low estimate of $7.0726. This indicates an +942.18% rise from the last price of $2.1451.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $14.15 | $14.30 | $16.94 | +559.66% |
| February, 2028 | $9.2652 | $9.6052 | $12.30 | +331.92% |
| March, 2028 | $29.03 | $7.0726 | $25.17 | +1,253% |
| April, 2028 | $21.41 | $22.41 | $25.37 | +897.96% |
| May, 2028 | $15.99 | $16.06 | $19.52 | +645.39% |
| June, 2028 | $9.2871 | $9.2871 | $13.71 | +332.95% |
| July, 2028 | $28.34 | $9.2865 | $31.40 | +1,221% |
| August, 2028 | $22.29 | $22.44 | $25.98 | +939.14% |
| September, 2028 | $14.93 | $15.27 | $19.83 | +596.06% |
| October, 2028 | $37.54 | $11.19 | $37.64 | +1,650% |
| November, 2028 | $30.61 | $30.61 | $34.54 | +1,327% |
| December, 2028 | $22.89 | $22.96 | $27.88 | +967.20% |
Niki BioSolutions, Inc. Common Stock Stock (NIKI) Price Forecast for 2029
The 2029 price forecast for Niki BioSolutions, Inc. Common Stock Stock (NIKI) is $37.84 on average, with a high prediction of $62.58 and a low estimate of $13.10. This represents an +1,664% increase from the previous price of $2.1451.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $13.10 | $13.10 | $20.00 | +510.55% |
| February, 2029 | $38.95 | $39.59 | $43.87 | +1,716% |
| March, 2029 | $30.43 | $30.58 | $35.97 | +1,319% |
| April, 2029 | $18.11 | $18.17 | $27.35 | +744.44% |
| May, 2029 | $49.39 | $15.00 | $50.11 | +2,202% |
| June, 2029 | $39.99 | $39.99 | $45.77 | +1,764% |
| July, 2029 | $26.66 | $26.90 | $36.64 | +1,143% |
| August, 2029 | $16.91 | $16.91 | $23.33 | +688.19% |
| September, 2029 | $49.57 | $50.21 | $56.34 | +2,211% |
| October, 2029 | $35.66 | $35.69 | $45.97 | +1,562% |
| November, 2029 | $23.16 | $23.22 | $32.08 | +979.74% |
| December, 2029 | $58.41 | $18.81 | $62.58 | +2,623% |
Niki BioSolutions, Inc. Common Stock Stock (NIKI) Price Forecast for 2030
Niki BioSolutions, Inc. Common Stock Stock (NIKI) is expected to reach an average price of $51.00 in 2030, with a high forecast of $81.28 and a low forecast of $20.72. This signifies an +2,278% surge from the last price of $2.1451.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $45.69 | $46.00 | $54.09 | +2,030% |
| February, 2030 | $32.95 | $33.19 | $39.16 | +1,436% |
| March, 2030 | $20.72 | $20.72 | $29.00 | +865.83% |
| April, 2030 | $56.39 | $57.39 | $68.81 | +2,529% |
| May, 2030 | $43.18 | $43.21 | $52.34 | +1,913% |
| June, 2030 | $28.21 | $28.26 | $38.98 | +1,215% |
| July, 2030 | $69.64 | $22.62 | $75.05 | +3,146% |
| August, 2030 | $54.45 | $54.76 | $64.70 | +2,438% |
| September, 2030 | $34.76 | $35.10 | $47.30 | +1,521% |
| October, 2030 | $85.14 | $24.53 | $81.28 | +3,869% |
| November, 2030 | $66.39 | $67.39 | $78.70 | +2,995% |
| December, 2030 | $47.05 | $47.13 | $61.72 | +2,094% |
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):